• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本头颈部癌症患者的中期和长期生存亚部位特异性趋势:一项基于人群的研究。

Subsite-specific trends in mid- and long-term survival for head and neck cancer patients in Japan: A population-based study.

机构信息

Division of Cancer Information and Control, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan.

Department of Otorhinolaryngology, Head and Neck Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

出版信息

Cancer Sci. 2024 Feb;115(2):623-634. doi: 10.1111/cas.16028. Epub 2023 Nov 23.

DOI:10.1111/cas.16028
PMID:37994633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10859624/
Abstract

Advances in diagnostic techniques and treatment modalities have impacted head and neck cancer (HNC) prognosis, but their effects on subsite-specific prognosis remain unclear. This study aimed to assess subsite-specific trends in mid- and long-term survival for HNC patients diagnosed from 1993 to 2011 using data from population-based cancer registries in Japan. We estimated the net survival (NS) for HNC by subsite using data from 13 prefectural population-based cancer registries in Japan. Changes in survival over time were assessed by multivariate excess hazard model of mortality. In total, 68,312 HNC patients were included in this analysis. We observed an overall improvement in 5-year NS for HNC patients in Japan. However, survival varied among subsites of HNC, with some, such as naso-, oro- and hypopharyngeal cancers, showing significant improvement in both 5- and 10-year NS, whereas others such as laryngeal cancer showed only a slight improvement in 5-year NS and no significant change in 10-year NS after adjustment for age, sex and stage. In conclusion, the study provides insights into changing HNC survival by site at the population level in Japan. Although advances in diagnostic techniques and treatment modalities have improved survival, these improvements are not shared equally among subsites.

摘要

诊断技术和治疗方式的进步已经影响了头颈部癌症(HNC)的预后,但它们对亚部位特异性预后的影响仍不清楚。本研究旨在使用日本基于人群的癌症登记处的数据,评估 1993 年至 2011 年间诊断的 HNC 患者的亚部位特异性中、长期生存趋势。我们使用来自日本 13 个都道府县基于人群的癌症登记处的数据,估计了 HNC 按亚部位的净生存率(NS)。通过多变量超额死亡风险模型评估了随时间变化的生存情况。共有 68312 名 HNC 患者纳入本分析。我们观察到日本 HNC 患者的 5 年 NS 总体上有所提高。然而,HNC 的亚部位之间的生存情况存在差异,一些部位,如鼻腔、口腔和下咽癌,在 5 年和 10 年 NS 方面均有显著改善,而其他部位,如喉癌,在 5 年 NS 方面仅略有改善,10 年 NS 则无明显变化,调整了年龄、性别和分期因素后。总之,本研究在日本人群水平上提供了对 HNC 按部位生存变化的深入了解。尽管诊断技术和治疗方式的进步提高了生存率,但这些改进在亚部位之间并不均等。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1190/10859624/eac635409424/CAS-115-623-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1190/10859624/eac635409424/CAS-115-623-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1190/10859624/eac635409424/CAS-115-623-g002.jpg

相似文献

1
Subsite-specific trends in mid- and long-term survival for head and neck cancer patients in Japan: A population-based study.日本头颈部癌症患者的中期和长期生存亚部位特异性趋势:一项基于人群的研究。
Cancer Sci. 2024 Feb;115(2):623-634. doi: 10.1111/cas.16028. Epub 2023 Nov 23.
2
Trends in the incidence of head and neck cancer by subsite between 1993 and 2015 in Japan.日本 1993 年至 2015 年间头颈部癌症各部位发病率的变化趋势。
Cancer Med. 2022 Mar;11(6):1553-1560. doi: 10.1002/cam4.4539. Epub 2022 Jan 14.
3
The changing face of Irish head and neck cancer epidemiology: 20 years of data.爱尔兰头颈部癌症流行病学的变化:20 年的数据。
Eur Arch Otorhinolaryngol. 2022 Jun;279(6):3079-3088. doi: 10.1007/s00405-021-07118-4. Epub 2021 Oct 13.
4
A Comparison of the NCDB and SEER Database for Research Involving Head and Neck Cancer.《头颈部癌症研究中 NCDB 与 SEER 数据库的比较》
Otolaryngol Head Neck Surg. 2019 Feb;160(2):284-294. doi: 10.1177/0194599818792205. Epub 2018 Aug 21.
5
25 year survival outcomes for squamous cell carcinomas of the head and neck: population-based outcomes from a Canadian province.25 年头颈部鳞状细胞癌的生存结果:来自加拿大一个省的基于人群的结果。
Oral Oncol. 2014 Jul;50(7):651-6. doi: 10.1016/j.oraloncology.2014.03.009. Epub 2014 Apr 14.
6
Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancers.头颈部癌症患者的纵向健康效用和症状毒性轨迹。
Cancer. 2022 Feb 1;128(3):497-508. doi: 10.1002/cncr.33936. Epub 2021 Oct 1.
7
Head and neck cancer in Cali, Colombia: Population-based study.哥伦比亚卡利的头颈部癌症:基于人群的研究。
Community Dent Oral Epidemiol. 2022 Aug;50(4):292-299. doi: 10.1111/cdoe.12671. Epub 2021 Jun 8.
8
Head and neck cancer in South East England between 1995-1999 and 2000-2004: An estimation of incidence and distribution by site, stage and histological type.1995-1999 年和 2000-2004 年英格兰东南部头颈部癌症:按部位、分期和组织学类型估计发病率和分布。
Oral Oncol. 2009 Sep;45(9):809-14. doi: 10.1016/j.oraloncology.2008.12.009. Epub 2009 Feb 28.
9
Trends in age-standardised net survival of stomach cancer by subsite and stage: A population-based study in Osaka, Japan, 2001-2014.日本大阪 2001-2014 年基于人群的胃肿瘤亚部位和分期的年龄标准化净生存率趋势研究。
Cancer Epidemiol. 2022 Aug;79:102170. doi: 10.1016/j.canep.2022.102170. Epub 2022 May 4.
10
Trends in epidemiology and treatment and outcome for head and neck cancer: a population-based long-term analysis from 1996 to 2011 of the Thuringian cancer registry.头颈癌的流行病学、治疗及预后趋势:基于图林根癌症登记处1996年至2011年的一项长期人群分析。
Oral Oncol. 2014 Dec;50(12):1157-64. doi: 10.1016/j.oraloncology.2014.09.015. Epub 2014 Oct 19.

引用本文的文献

1
Deciphering Nicotine-Driven Oncogenesis in Head and Neck Cancer: Integrative Transcriptomics and Drug Repurposing Insights.解析头颈癌中尼古丁驱动的肿瘤发生:整合转录组学与药物再利用见解
Cancers (Basel). 2025 Apr 24;17(9):1430. doi: 10.3390/cancers17091430.
2
Comparative Net Survival Analysis of Men and Women With Breast Cancer in Japan: A Population-Based Study.日本乳腺癌男性和女性的比较净生存分析:一项基于人群的研究。
Cancer Sci. 2025 Jul;116(7):1963-1971. doi: 10.1111/cas.70068. Epub 2025 Mar 31.
3
Individualized treatment recommendations for patients with locally advanced head and neck squamous cell carcinoma utilizing deep learning.

本文引用的文献

1
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019.韩国癌症统计数据:2019 年的发病率、死亡率、生存率和流行率。
Cancer Res Treat. 2022 Apr;54(2):330-344. doi: 10.4143/crt.2022.128. Epub 2022 Mar 16.
2
Trends in the incidence of head and neck cancer by subsite between 1993 and 2015 in Japan.日本 1993 年至 2015 年间头颈部癌症各部位发病率的变化趋势。
Cancer Med. 2022 Mar;11(6):1553-1560. doi: 10.1002/cam4.4539. Epub 2022 Jan 14.
3
Guideline - Adherence in advanced stage head and neck cancer is associated with improved survival - A National study.
利用深度学习为局部晚期头颈部鳞状细胞癌患者提供个性化治疗建议。
Front Med (Lausanne). 2025 Jan 6;11:1478842. doi: 10.3389/fmed.2024.1478842. eCollection 2024.
4
MiRNA Profiling of Areca Nut-Induced Carcinogenesis in Head and Neck Cancer.槟榔诱导头颈癌发生的微小RNA谱分析
Cancers (Basel). 2024 Nov 3;16(21):3710. doi: 10.3390/cancers16213710.
5
Laryngeal cancer relative survival trends from 1972 to 2021 in the Nordic countries.1972 年至 2021 年北欧国家喉癌相对生存趋势。
Acta Oncol. 2024 Aug 4;63:612-619. doi: 10.2340/1651-226X.2024.40823.
6
Induction of Immunological Antitumor Effects by the Combination of Adenovirus-Mediated Gene Transfer of B7-1 and Anti-Programmed Cell Death-1 Antibody in a Murine Squamous Cell Carcinoma Model.在小鼠鳞状细胞癌模型中,通过腺病毒介导的B7-1基因转移与抗程序性细胞死亡-1抗体联合诱导免疫抗肿瘤效应。
Cancers (Basel). 2024 Mar 30;16(7):1359. doi: 10.3390/cancers16071359.
指南 - 晚期头颈部癌症的依从性与生存改善相关 - 一项全国性研究。
Oral Oncol. 2022 Feb;125:105694. doi: 10.1016/j.oraloncology.2021.105694. Epub 2021 Dec 28.
4
Stage Migration and Survival Trends in Laryngeal Cancer.喉癌的分期转移和生存趋势。
Ann Surg Oncol. 2021 Nov;28(12):7300-7309. doi: 10.1245/s10434-021-10318-1. Epub 2021 Jul 15.
5
[Trends in the Detail of the Stage and Survival Rate in Hypopharyngeal Cancer over 20 Years].[下咽癌20年分期细节与生存率的变化趋势]
Nihon Jibiinkoka Gakkai Kaiho. 2016 Jul;119(7):949-54.
6
Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinoma.系统评价和荟萃分析强度调制放疗与常规二维和/或三维放疗在头颈部鳞状细胞癌根治性治疗中的应用。
PLoS One. 2018 Jul 6;13(7):e0200137. doi: 10.1371/journal.pone.0200137. eCollection 2018.
7
Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study.21世纪初在欧洲诊断出的头颈癌的预后与改善情况:基于人群的EUROCARE-5研究
Eur J Cancer. 2015 Oct;51(15):2130-2143. doi: 10.1016/j.ejca.2015.07.043. Epub 2015 Sep 26.
8
Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis.调强放射治疗与二维放疗或三维适形放疗治疗鼻咽癌的系统评价和荟萃分析
Oral Oncol. 2015 Nov;51(11):1041-1046. doi: 10.1016/j.oraloncology.2015.08.005. Epub 2015 Aug 18.
9
Survival trends in hypopharyngeal cancer: a population-based review.下咽癌的生存趋势:一项基于人群的综述。
Laryngoscope. 2015 Mar;125(3):624-9. doi: 10.1002/lary.24915. Epub 2014 Sep 15.
10
Current status of oral cancer treatment strategies: surgical treatments for oral squamous cell carcinoma.口腔癌治疗策略的现状:口腔鳞状细胞癌的外科治疗
Int J Clin Oncol. 2014;19(3):423-30. doi: 10.1007/s10147-014-0689-z. Epub 2014 Apr 1.